6 Month Real World Experience Study Confirms Efficacy and Safety of SING IMT ® for Late-Stage Age-Related Macular Degeneration

6 Month Real World Experience Study Confirms Efficacy and Safety of SING IMT ® for Late-Stage Age-Related Macular Degeneration

Published in the journal Heliyon, the new study found that SING IMT improved both distance and near vision — while exhibiting minimal effects on corneal endothelial cell density and a favorable safety profile.

← Previous
Next →
  • HEALTH / LIFESTYLE
  • ARTICLES OF INTERST
  • ABOUT
    • EDITORIAL
    • SUBMIT PRESS RELEASES
  • ADVERTISE
  • CONTACT
  • PRIVACY
    • COOKIE POLICY
  • HEALTH / LIFESTYLE
  • ARTICLES OF INTERST
  • ABOUT
    • EDITORIAL
    • SUBMIT PRESS RELEASES
  • ADVERTISE
  • CONTACT
  • PRIVACY
    • COOKIE POLICY

© 2026 All rights Reserved. Medical Device News Magazine, is a Division of PTM Healthcare Marketing, Inc.